Covaxin
AIIMS to start recruitment for Covaxin clinical trial in 6-12 age group from Tuesday
This will be followed by the clinical trial of children in the age-group of 2-6 years
Covid vaccine booster can increase immunity, help combat variants: AIIMS doctor
IIMS Delhi started the clinical trials of the third dose of the COVAXIN, as a booster dose, six months after administering the second dose
Centre places order for 44 cr doses of COVID-19 vaccines
AIIMS director said there is no data to show that children will be seriously infected in subsequent Covid-19 waves
Centre to provide free vaccine to states for those over 18 yrs from June 21: PM Modi
The Centre has decided to buy 75 per cent of jabs from vaccine makers
Covishield produced more antibodies than Covaxin, says preliminary study
The study is a preprint and has not been peer-reviewed
US students who took India's Covaxin, Russia's Sputnik V, asked to get re-vaccinated
American students have access to the Pfizer, Moderna and Johnson & Johnson vaccines
SC slams Centre’s vaccination policy as ‘irrational’, asks for purchase data
The top court also sought data on the percentage of population that has been vaccinated (with one dose and both doses)
COVID cases, positivity rate take a dip in Delhi, but black fungus a big worry
The Centre said that India was the second country after the United States to cross 20 crore cumulative Covid-19 vaccination coverage
Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by July-Sept
The WHO has given approvals to the Pfizer/BioNTech vaccine for emergency use on December 31
Probal DasGupta | India can vaccinate swiftly by using ‘mohalla method’
A swifter pace of vaccinations is the antidote to arrest fatality numbers, build confidence and encourage a quicker economic revival